French drug major Sanofi (SNY) and Regeneron Pharmaceuticals, Inc. (REGN) announced Friday that the U.S. Food and Drug Administration ...

Sanofi (SNY) has released an update. Sanofi’s Dupixent has received EU approval as the first treatment for children aged one to 11 with ...

Delve into Sanofi's "play to win" strategy as investments are ramping up after their consumer health division's divestment.

For anything urgent (e.g., to report a suspected fraudulent transaction), call us immediately at +33 153 75 83 00 In March 2008 Standard Chartered opened in France, and has been serving the needs of ...

According to John Hollinger of The Athletic, Risacher gave an honest assessment of his situation during training camp, saying: "Back in France I was super athletic, and now I'm just a regular dude." ...

The iconic Carrefour logo is a brilliant demonstration of how negative space in a design can convey a more profound meaning about a brand. When Carrefour was founded in 1959 in Annecy, France, the ...

(RTTNews) - Sanofi announced that Beyfortus (nirsevimab) will be broadly available for babies born in Ontario, Quebec, Nunavut, Northwest Territories, and the Yukon this fall. The administration ...

The former head of cancer drugmaker Seagen has joined a new startup involved in what’s recently become a competitive corner of oncology research. The startup, Ottimo Pharma, emerged from stealth ...

Although competition is fierce this weekend with El Clasico between Real Madrid and Barcelona on Saturday, this weekend is actually perfect to catch some high stakes action in France's Ligue 1 ...

Sanofi (NASDAQ:SNY) shares gained on Friday after the French pharma giant exceeded analysts' estimates with its Q3 thanks mainly to earlier-than-anticipated vaccine sales and a 22% YoY rise in ...

Despite Merck & Co. homing in on approval for its infant respiratory syncytial virus (RSV) antibody clesrovimab, Sanofi—which last year won its own nod for its AstraZeneca-partnered RSV ...

The pharmaceutical company reported third-quarter earnings and sales that beat analysts’ expectations, boosted by ...